B. Aronsson
Impact in
- Infectious Diseases top 2%
- Clostridium difficile and Clostridium perfringens research
-
- Antibiotic Use and Resistance
Papers in
-
- Clostridium difficile and Clostridium perfringens research 19
-
- Pharmaceutical industry and healthcare 4
- Co-authors
- R. Möllby (13 shared papers)Carl Erik Nord (12 shared papers)Anna Schwan (2 shared papers)STIG SJÖLIN (2 shared papers)Marta Granström (5 shared papers)Anthony D. So (1 shared paper)Inge C. Gyssens (1 shared paper)Dominique L. Monnet (1 shared paper)
- Journals
- Scandinavian Journal of Infectious Diseases (5 papers)European Journal of Clinical Microbiology & Infectious Diseases (4 papers)Infection (3 papers)European Journal of Clinical Pharmacology (2 papers)Nature Reviews Drug Discovery (2 papers)
- Partner nations
- SwedenNetherlandsUnited Kingdom
In The Last Decade
B. Aronsson
41 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 109
- Infectious Diseases 799
- Applied Microbiology and Biotechnology 64
- Molecular Medicine 57
- Health Information Management 44
- Pharmacology 47
Countries citing papers authored by B. Aronsson
This map shows the geographic impact of B. Aronsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Aronsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Aronsson more than expected).
Fields of papers citing papers by B. Aronsson
This network shows the impact of papers produced by B. Aronsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Aronsson. The network helps show where B. Aronsson may publish in the future.
Co-authors
The 25 scholars most cited alongside B. Aronsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 275 | |
| 2 | 1985 | 212 | |
| 3 | 1984 | 171 | |
| 4 | 1985 | 101 | |
| 5 | 2009 | 93 | |
| 6 | 1989 | 92 | |
| 7 | 1984 | 70 | |
| 8 | 2009 | 49 | |
| 9 | 1992 | 46 | |
| 10 | 1984 | 43 | |
| 11 | 1981 | 38 | |
| 12 | 2009 | 38 | |
| 13 | 1981 | 37 | |
| 14 | 1987 | 36 | |
| 15 | 1994 | 35 | |
| 16 | Clostridium difficile and antibiotic associated diarrhoea in Sweden. | 1982 | 33 |
| 17 | 1983 | 33 | |
| 18 | Diagnosis of Clostridium difficile-associated enterocolitis in Sweden. Laboratory and epidemiological aspects. | 1980 | 32 |
| 19 | 1994 | 32 | |
| 20 | 2002 | 31 |
About B. Aronsson
B. Aronsson is a scholar working on Infectious Diseases, Pharmacology, Economics and Econometrics, Epidemiology and Molecular Medicine, having authored 41 papers that have together received 1.7k indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (19 papers), Pharmaceutical Economics and Policy (5 papers), Hepatitis B Virus Studies (4 papers), Pharmaceutical industry and healthcare (4 papers), Hepatitis C virus research (2 papers), Healthcare Regulation (2 papers), Antibiotic Resistance in Bacteria (2 papers) and Innovations in Medical Education (1 paper). The work is most often cited by research in Infectious Diseases (799 citations), Applied Microbiology and Biotechnology (64 citations), Molecular Medicine (57 citations), Health Information Management (44 citations) and Pharmacology (47 citations). B. Aronsson has collaborated with scholars based in Sweden, Netherlands and United Kingdom. Frequent co-authors include R. Möllby, Carl Erik Nord, Anna Schwan, STIG SJÖLIN, Marta Granström, Anthony D. So, Inge C. Gyssens, Dominique L. Monnet, Otto Cars and Ola Weiland. Their work appears in journals such as Scandinavian Journal of Infectious Diseases, European Journal of Clinical Microbiology & Infectious Diseases, Infection, European Journal of Clinical Pharmacology and Nature Reviews Drug Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.